Alex received his BSc in Biochemistry from the University of Kent at Canterbury in 1990. He then moved to the MRC Laboratory of Molecular Biology in Cambridge, where his PhD research focused on the molecular biology and biochemistry of myosin molecular motors in plants and animals. After receiving his PhD from the University of Cambridge in 1994, he moved to the Whitehead Institute for Biomedical Research in Cambridge, MA, USA, as an EMBO postdoctoral fellow and began an enduring fascination with single molecule biophysics. In 1996 he moved back to the UK and the laboratory of Justin Molloy at the University of York, where he built optical tweezers and single-molecule fluorescence imaging systems to study myosins (again). In 2002, he moved to NPL where he was involved in setting up the new Biotechnology Group and in 2009 was promoted to Principal Research Scientist. At NPL he led and delivered numerous projects applying innovative measurement approaches to biomedical problems. He developed a succesful new research area in super-resolution microscopy and also led research on point of care diagnostics. Alex has wide experience managing collaborative projects and working in partnership with industry, academia and clinicians, including acting as chief investigator on the £1.2M NIHR i4i “RegeniTherix” project, which developed and tested diagnostic devices for monitoring the healing of chronic wounds. Alex is a Fellow of the Royal Microscopical Society and an IUPAC fellow, and has published over 45 peer-reviewed papers and reviews and edited the book Single Molecule Biology.
Graduating from Mysore University, India in 1981, Shervanthi Homer-Vanniasinkam became a Fellow of the Royal College of Surgeons of Edinburgh in 1989 and a Fellow of the Royal College of Surgeons of England in 1998. She was appointed Consultant Vascular Surgeon at Leeds General Infirmary in 1995, a post she continues to hold. She is also Clinical Sub-Dean, University of Leeds Medical School and Director of EXSEL@Leeds; Founding Professor of Surgery, University of Warwick Medical School & University Hospitals Coventry and Warwickshire, and Professor of Engineering and Surgery, University College London. Shervanthi has published 127 papers and book chapters and has given over 300 invited presentations worldwide. She is also a non-executive director at Tissue Regenix and serves on many committees and advisory boards.
Louise is also Chief Executive Officer of Complement Genomics and is a post graduate in Medical Genetics, having carried our research into the genetics of colon cancer.
Neil has been involved in genetic testing and molecular biology for over 30 years and is the author of over 40 original publications and three books. His current role in the company is in new business development and marketing.